Filed with ASX · · 2 pages · English
The webinar will feature the Chair and CEO, Steve Wedan, along with CFO Jonathon Gut, and will take place in the morning of the same day as the results release. Investors are encouraged to submit questions prior to the webinar.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Q3 FY26 RESULTS WEBINAR NOTIFICATION 30 October 2026 – Melbourne, Australia (29 October 2026 – Minneapolis, MN United States) – Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce it will release its Q3 FY26 results for the period ending 30 September 2026...
Imricor Medical Systems, Inc. on 6ix
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems